ONTOLOGY REPORT - ANNOTATIONS
Term: budesonide
Accession: CHEBI:3207
browse the term
Definition: A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.
Synonyms: exact_synonym: 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
related_synonym: (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; C25H34O6; InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1; InChIKey=VOVIALXJUBGFJZ-KWVAZRHASA-N; [H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])C[C@H]2OC(CCC)O[C@@]12C(=O)CO
xref_casrn: 51333-22-3
xref: ChEMBL:413314 "ChEMBL COMPOUND"; ChemIDplus:51333-22-3 "CAS Registry Number"; CiteXplore:21616561 "PubMed citation"; DrugBank:DB01222 "DrugBank"; KEGG DRUG:51333-22-3 "CAS Registry Number"; KEGG DRUG:D00246 "KEGG DRUG"
xref_mesh: MESH:D019819
xref: Patent:DE2323215 "Patent"; Patent:US3929768 "Patent"; Wikipedia:Budesonide "Wikipedia"
budesonide
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases expression
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Adrb2
adrenoceptor beta 2, surface
increases expression
ISO
18
58,174,958
58,177,000
RGD:6480464
CTD
G
Ar
androgen receptor
multiple interactions
ISO
X
85,949,507
86,119,199
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
decreases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
RGD:6480464
CTD
G
Casp3
caspase 3
decreases expression
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Ccl17
chemokine (C-C motif) ligand 17
decreases expression
ISO
19
10,641,376
10,642,827
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases expression
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
multiple interactions
EXP
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl3
chemokine (C-C motif) ligand 3
increases expression
ISO
10
71,744,559
71,746,109
RGD:6480464
CTD
G
Ccl4
chemokine (C-C motif) ligand 4
increases expression
ISO
10
71,759,643
71,761,115
RGD:6480464
CTD
G
Ccnb2
cyclin B2
decreases expression
ISO
8
74,892,108
74,906,181
RGD:6480464
CTD
G
Ccne1
cyclin E1
decreases expression
ISO
1
90,568,189
90,577,426
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
4
171,841,705
171,846,506
RGD:6480464
CTD
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
decreases secretion
ISO
10
39,665,850
39,667,831
RGD:6480464
CTD
G
Cxcl1
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
multiple interactions
EXP
14
18,690,339
18,692,118
RGD:6480464
CTD
G
Cxcl2
chemokine (C-X-C motif) ligand 2
multiple interactions
EXP
14
18,677,129
18,679,175
RGD:6480464
CTD
G
Cxcl3
chemokine (C-X-C motif) ligand 3
multiple interactions
EXP
14
18,767,306
18,787,340
RGD:6480464
CTD
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression
EXP
12
9,517,016
9,541,000
RGD:6480464
CTD
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
12
17,164,384
17,204,589
RGD:6480464
CTD
G
Gcg
glucagon
decreases expression
EXP
3
44,433,180
44,438,004
RGD:6480464
CTD
G
Gcg
glucagon
multiple interactions
EXP
3
44,433,180
44,438,004
RGD:6480464
CTD
G
Ifng
interferon gamma
decreases secretion
ISO
7
57,621,756
57,625,792
RGD:6480464
CTD
G
Ifng
interferon gamma
multiple interactions
ISO
7
57,621,756
57,625,792
RGD:6480464
CTD
G
Igf2
insulin-like growth factor 2
multiple interactions
ISO
1
202,906,624
202,915,231
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
decreases secretion
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
EXP
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il4
interleukin 4
decreases expression
ISO
10
39,074,582
39,080,134
RGD:6480464
CTD
G
Il4
interleukin 4
decreases expression
ISO
10
39,074,582
39,080,134
RGD:6480464
CTD
G
Il4r
interleukin 4 receptor
decreases expression
ISO
1
184,612,903
184,637,863
RGD:6480464
CTD
G
Il5
interleukin 5
decreases expression
ISO
10
39,177,786
39,180,657
RGD:6480464
CTD
G
Il5
interleukin 5
decreases expression
ISO
10
39,177,786
39,180,657
RGD:6480464
CTD
G
Il6
interleukin 6
multiple interactions
EXP
4
456,799
461,376
RGD:6480464
CTD
G
Jun
jun proto-oncogene
decreases expression
EXP
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
multiple interactions
EXP
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Mpo
myeloperoxidase
multiple interactions
EXP
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Mt2A
metallothionein 2A
increases expression
ISO
19
11,267,811
11,268,585
RGD:6480464
CTD
G
Mt2A
metallothionein 2A
multiple interactions
ISO
19
11,267,811
11,268,585
RGD:6480464
CTD
G
Myc
myelocytomatosis oncogene
multiple interactions
ISO
7
98,953,142
98,958,060
RGD:6480464
CTD
G
Nos2
nitric oxide synthase 2, inducible
decreases expression
ISO
10
65,036,884
65,072,453
RGD:6480464
CTD
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP
10
65,036,884
65,072,453
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases activity
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases activity
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases activity
ISO
18
32,371,496
32,459,145
RGD:6480464
CTD
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
3
120,008,715
120,012,589
RGD:6480464
CTD
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
7
123,729,774
123,807,090
RGD:6480464
CTD
G
Ptges2
prostaglandin E synthase 2
multiple interactions
EXP
3
11,521,214
11,528,395
RGD:6480464
CTD
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
3
15,343,832
15,365,412
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
1
208,262,669
208,273,148
RGD:6480464
CTD
G
Rnase17
ribonuclease 17
decreases expression
ISO
15
27,259,616
27,260,083
RGD:6480464
CTD
G
Sele
selectin E
multiple interactions
EXP
13
79,813,455
79,822,845
RGD:6480464
CTD
G
Sell
selectin L
multiple interactions
EXP
13
79,827,342
79,845,296
RGD:6480464
CTD
G
Selp
selectin P
multiple interactions
EXP
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Slc22a3
solute carrier family 22 (extraneuronal monoamine transporter), member 3
multiple interactions
ISO
1
42,690,158
42,781,895
RGD:6480464
CTD
G
Slco1b3
solute carrier organic anion transporter family, member 1b3
multiple interactions
ISO
4
179,045,586
179,118,680
RGD:6480464
CTD
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
multiple interactions
ISO
1
156,992,492
157,028,887
RGD:6480464
CTD
G
Spp1
secreted phosphoprotein 1
increases expression
ISO
RGD:6480464
CTD
G
Tgm2
transglutaminase 2, C polypeptide
increases expression
ISO
3
148,832,866
148,862,385
RGD:6480464
CTD
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
X
12,542,496
12,547,094
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases expression
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases secretion
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tp53
tumor protein p53
decreases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
EXP
2
212,277,654
212,297,376
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest